Stock Events

Stock Events

Oncologix Tech 

$0.000100
4
+$0.00+0% Thursday 20:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0001
52W Low
0.0001
Volume
198,200
Avg. Volume
40,814
Mkt Cap
27,674.6
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30NovExpected
Q1 2016
Q2 2016
Q3 2016
Q4 2016
Q1 2017
Q2 2017
Q3 2017
-0
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.0003

Financials

-35.68%Profit Margin
Unprofitable
2012
2013
2014
7.35MRevenue
-2.62MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical company that develops and markets drugs in various therapeutic areas, including oncology, directly competing with Oncologix Tech's focus on cancer treatments.
Merck
MRK
Mkt Cap366B
Merck & Co. is a leading healthcare company that offers innovative cancer treatments and vaccines, making it a direct competitor in the oncology sector.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb is involved in the discovery, development, and delivery of cancer medicines, competing in the same oncology space as Oncologix Tech.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical segment, develops and sells oncology drugs, positioning it as a competitor in the cancer treatment market.
Novartis
NVS
Mkt Cap292.35B
Novartis AG is a global healthcare company that has a significant presence in the oncology sector, offering cancer treatments that compete with Oncologix Tech's products.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie is a biopharmaceutical company that develops and markets therapies in oncology, making it a competitor in the cancer treatment market.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biotechnology company focusing on human therapeutics, including oncology, which competes with Oncologix Tech in developing cancer treatments.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is a biopharmaceutical company that develops and markets innovative medicines in areas of unmet medical need, including oncology.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including those for cancer, competing with Oncologix Tech.

About

Oncologix Tech, Inc. is a biopharmaceutical company whose main products include DNAGO and genomego which provides clinical genetic testing on all 20,000+ genes encompassing over 7,000 rare genetic diseases. It also previously operated in personal home care services and the manufacturing and distribution of medical technologies. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007.
Show more...
CEO
Michael A. Kramarz
Employees
191
Country
United States
ISIN
US68230M2098

Listings

OTC Link
US
OCLG

0 Comments

Share your thoughts

FAQ

What is Oncologix Tech stock price today?▼
The current price of OCLG is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Oncologix Tech stock price performance more closely on the chart.
What is Oncologix Tech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Oncologix Tech stocks are traded under the ticker OCLG.
Is Oncologix Tech stock price growing?▼
OCLG stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Oncologix Tech has showed a +0% increase.
What is Oncologix Tech market cap?▼
Today Oncologix Tech has the market capitalization of 27,674.6
What were Oncologix Tech earnings last quarter?▼
OCLG earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Oncologix Tech revenue for the last year?▼
Oncologix Tech revenue for the last year amounts to 7.35M USD.
What is Oncologix Tech net income for the last year?▼
OCLG net income for the last year is -2.62M USD.
How many employees does Oncologix Tech have?▼
As of September 04, 2026, the company has 191 employees.
In which sector is Oncologix Tech located?▼
Oncologix Tech operates in the Finance & Payments sector.
When did Oncologix Tech complete a stock split?▼
Oncologix Tech has not had any recent stock splits.
Where is Oncologix Tech headquartered?▼
Oncologix Tech is headquartered in Lafayette, United States.